Keeping Track: Resubmissions For Tlando And Twirla NDAs, And A BTD For Pomalyst

 
• By Michael Cipriano

The latest drug development news and highlights from our US FDA Performance Tracker.

Keeping Track Feature image

More from Product Reviews

More from Pink Sheet